SMURF2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.225400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.146800E-01
Normal-vs-Stage2
8.191800E-01
Normal-vs-Stage3
6.857600E-02
Normal-vs-Stage4
9.123000E-01
Stage1-vs-Stage2
3.561800E-01
Stage1-vs-Stage3
3.557200E-01
Stage1-vs-Stage4
2.183400E-01
Stage2-vs-Stage3
1.641240E-01
Stage2-vs-Stage4
8.642600E-01
Stage3-vs-Stage4
6.574300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.622200E-01
Normal-vs-AfricanAmerican
4.348000E-01
Normal-vs-Asian
3.022600E-01
Caucasian-vs-AfricanAmerican
1.732750E-01
Caucasian-vs-Asian
3.251200E-01
AfricanAmerican-vs-Asian
1.044380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.288400E-01
Normal-vs-Female
7.233400E-01
Male-vs-Female
7.900400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.579600E-01
Normal-vs-Age(41-60Yrs)
7.913800E-01
Normal-vs-Age(61-80Yrs)
5.242400E-01
Normal-vs-Age(81-100Yrs)
2.258600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.806800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.864800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.057600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.839160E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.584100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.463000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.298400E-01
Normal-vs-Daily Drinker
1.961430E-01
Normal-vs-Weekly Drinker
3.347600E-01
Normal-vs-Occasional Drinker
9.157600E-01
Normal-vs-Social Drinker
9.244600E-01
Non Drinker-vs-Daily Drinker
4.240600E-01
Non Drinker-vs-Weekly Drinker
8.802000E-01
Non Drinker-vs-Occasional Drinker
1.487800E-01
Non Drinker-vs-Social Drinker
7.299900E-02
Daily Drinker-vs-Weekly Drinker
4.609600E-01
Daily Drinker-vs-Occasional Drinker
7.824400E-02
Daily Drinker-vs-Social Drinker
4.054400E-02
Weekly Drinker-vs-Occasional Drinker
2.000400E-01
Weekly Drinker-vs-Social Drinker
1.975960E-01
Occasional Drinker-vs-Social Drinker
7.300400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.602600E-01
Normal-vs-Grade 2
1.641230E-01
Normal-vs-Grade 3
7.613700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.796440E-01
Grade 1-vs-Grade 3
4.686400E-02
Grade 1-vs-Grade 4
3.602600E-01
Grade 2-vs-Grade 3
3.443200E-01
Grade 2-vs-Grade 4
1.641230E-01
Grade 3-vs-Grade 4
7.613700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.399000E-01
Normal-vs-NonDiabetic
7.042000E-01
Diabetic-vs-NonDiabetic
2.633600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.796000E-01
Normal-vs-NoPancreatitis
6.562600E-01
Pancreatitis-vs-NoPancreatitis
7.437200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.542800E-01
Normal-vs-N1
7.819000E-01
N0-vs-N1
5.410600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.057200E-01
Normal-vs-TP53-NonMutant
6.326800E-01
TP53-Mutant-vs-TP53-NonMutant
2.087400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
